Acute Cholecystitis Following Ipilimumab and Nivolumab Treatment for Metastatic Melanoma

被引：0
|
作者：
Somerset, Amy E. [1 ,2 ]
Field, Bradley M. [1 ]
Webber, John D. [1 ]
Edelman, David A. [1 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Surg, Michael & Marian Ilitch, Detroit, MI USA
[2] Wayne State Univ Sch Med, Dept Surg, Michael & Marian Ilitch, 3990 John R, Detroit, MI 48201 USA
来源：
AMERICAN SURGEON | 2023年 / 89卷 / 02期
关键词：
D O I：
10.1177/0003134820966274
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Eosinophilic Pneumonia Following Treatment with Nivolumab-Ipilimumab for Metastatic Melanoma
    Wajda, N. A.
    Pina, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma
    Montaudie, Henri
    Picard, Alexandra
    Panaia-Ferrari, Patricia
    Boukari, Feriel
    Passeron, Thierry
    Sadoul, Jean-Louis
    Brucker-Davis, Francoise
    MELANOMA RESEARCH, 2018, 28 (04) : 368 - 369
  • [3] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Mansouri, Alireza
    Moraes, Fabio Y.
    Zadeh, Gelareh
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178
  • [4] Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab
    Tomsitz, D.
    Hein, R.
    Biedermann, T.
    Kohlmeyer, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : E26 - E28
  • [5] US FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
    Hazarika, Maitreyee
    Chuk, Meredith K.
    Theoret, Marc R.
    Mushti, Sirisha
    He, Kun
    Weis, Shawna L.
    Putman, Alexander H.
    Helms, Whitney S.
    Cao, Xianhua
    Li, Hongshan
    Zhao, Hong
    Zhao, Liang
    Welch, Joel
    Graham, Laurie
    Libeg, Meredith
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3484 - 3488
  • [6] Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Tawbi, Hussein A.
    Forsyth, Peter A.
    Algazi, Alain
    Hamid, Omid
    Hodi, F. Stephen
    Moschos, Stergios J.
    Khushalani, Nikhil I.
    Lewis, Karl
    Lao, Christopher D.
    Postow, Michael A.
    Atkins, Michael B.
    Ernstoff, Marc S.
    Reardon, David A.
    Puzanov, Igor
    Kudchadkar, Ragini R.
    Thomas, Reena P.
    Tarhini, Ahmad
    Pavlick, Anna C.
    Jiang, Joel
    Avila, Alexandre
    Demelo, Sheena
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 722 - 730
  • [7] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain Reply
    Tawbi, Hussein A.
    Chung, Caroline
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2178 - 2178
  • [8] Nivolumab in combination with ipilimumab for the treatment of melanoma
    Somasundaram, Rajasekharan
    Herlyn, Meenhard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1135 - 1141
  • [9] Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma
    Lasocki, Arian
    Smith, Kortnye
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 240 - 241
  • [10] Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
    Karivedu, Vidhya
    Eldessouki, Ihab
    Taftaf, Ahmad
    Zhu, Zheng
    Makramalla, Abouelmagd
    Karim, Nagla Abdel
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
12345